Cargando…

Management of Acute Cystitis in the Era of COVID-19

PURPOSE OF REVIEW: No specific guidelines have been developed for acute cystitis management during the COVID-19 pandemic. This review aims to provide up-to-date information about treatment and follow-up in patients with symptoms suggesting lower urinary tract infection. RECENT FINDINGS: Uncomplicate...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández-Hernández, David, Ortega-González, Yanira, Padilla-Fernández, Bárbara, Gutiérrez-Hernández, Pedro Ramón, Castro-Díaz, David Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684745/
https://www.ncbi.nlm.nih.gov/pubmed/36466948
http://dx.doi.org/10.1007/s11884-022-00677-0
_version_ 1784835360436518912
author Hernández-Hernández, David
Ortega-González, Yanira
Padilla-Fernández, Bárbara
Gutiérrez-Hernández, Pedro Ramón
Castro-Díaz, David Manuel
author_facet Hernández-Hernández, David
Ortega-González, Yanira
Padilla-Fernández, Bárbara
Gutiérrez-Hernández, Pedro Ramón
Castro-Díaz, David Manuel
author_sort Hernández-Hernández, David
collection PubMed
description PURPOSE OF REVIEW: No specific guidelines have been developed for acute cystitis management during the COVID-19 pandemic. This review aims to provide up-to-date information about treatment and follow-up in patients with symptoms suggesting lower urinary tract infection. RECENT FINDINGS: Uncomplicated cystitis does not need microbiological confirmation; thus, clinical diagnosis via telephone interview or questionnaires may be done. When complicated infections are suspected, in-person evaluation or close follow-up is mandatory. Antibiotic treatment is still the gold standard for treatment, although non-pharmacological strategies have also been suggested and further investigations are warranted. SUMMARY: Urinary tract infections are still a frequent reason for consultation that needs to be addressed in both primary care and specialized levels. Their management during the pandemic is similar than in precedent years, but telehealth options have emerged which can facilitate diagnosis and treatment.
format Online
Article
Text
id pubmed-9684745
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-96847452022-11-28 Management of Acute Cystitis in the Era of COVID-19 Hernández-Hernández, David Ortega-González, Yanira Padilla-Fernández, Bárbara Gutiérrez-Hernández, Pedro Ramón Castro-Díaz, David Manuel Curr Bladder Dysfunct Rep Inflammatory/Infectious Bladder Disorders (MS Mourad, Section Editor) PURPOSE OF REVIEW: No specific guidelines have been developed for acute cystitis management during the COVID-19 pandemic. This review aims to provide up-to-date information about treatment and follow-up in patients with symptoms suggesting lower urinary tract infection. RECENT FINDINGS: Uncomplicated cystitis does not need microbiological confirmation; thus, clinical diagnosis via telephone interview or questionnaires may be done. When complicated infections are suspected, in-person evaluation or close follow-up is mandatory. Antibiotic treatment is still the gold standard for treatment, although non-pharmacological strategies have also been suggested and further investigations are warranted. SUMMARY: Urinary tract infections are still a frequent reason for consultation that needs to be addressed in both primary care and specialized levels. Their management during the pandemic is similar than in precedent years, but telehealth options have emerged which can facilitate diagnosis and treatment. Springer US 2022-11-22 2023 /pmc/articles/PMC9684745/ /pubmed/36466948 http://dx.doi.org/10.1007/s11884-022-00677-0 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Inflammatory/Infectious Bladder Disorders (MS Mourad, Section Editor)
Hernández-Hernández, David
Ortega-González, Yanira
Padilla-Fernández, Bárbara
Gutiérrez-Hernández, Pedro Ramón
Castro-Díaz, David Manuel
Management of Acute Cystitis in the Era of COVID-19
title Management of Acute Cystitis in the Era of COVID-19
title_full Management of Acute Cystitis in the Era of COVID-19
title_fullStr Management of Acute Cystitis in the Era of COVID-19
title_full_unstemmed Management of Acute Cystitis in the Era of COVID-19
title_short Management of Acute Cystitis in the Era of COVID-19
title_sort management of acute cystitis in the era of covid-19
topic Inflammatory/Infectious Bladder Disorders (MS Mourad, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684745/
https://www.ncbi.nlm.nih.gov/pubmed/36466948
http://dx.doi.org/10.1007/s11884-022-00677-0
work_keys_str_mv AT hernandezhernandezdavid managementofacutecystitisintheeraofcovid19
AT ortegagonzalezyanira managementofacutecystitisintheeraofcovid19
AT padillafernandezbarbara managementofacutecystitisintheeraofcovid19
AT gutierrezhernandezpedroramon managementofacutecystitisintheeraofcovid19
AT castrodiazdavidmanuel managementofacutecystitisintheeraofcovid19